BlackRock, Inc. 13D and 13G filings for Xeris Biopharma Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-07-12 08:29 am Sale |
2021-06-30 | 13G | Xeris Biopharma Holdings, Inc. XERS |
BlackRock Inc. BLK |
1,684,166 2.500% |
-1,963,052 (-53.82%) |
Filing |
| 2021-02-01 08:30 am Purchase |
2020-12-31 | 13G | Xeris Biopharma Holdings, Inc. XERS |
BlackRock Inc. BLK |
3,647,218 7.400% |
1,450,471 (+66.03%) |
Filing |